The Anti-Infective Drugs Market continues to play a foundational role in global healthcare systems, addressing a broad spectrum of bacterial, viral, fungal, and parasitic infections. Valued at US$ 134,267.21 Million in 2024, the market is projected to expand at a CAGR of 3.1% from 2025 to 2032. Despite moderate growth, sustained demand is supported by rising infectious disease prevalence,...

Latest Insights on Executive Summary Anti-Metabolite Drugs Market Share and Size Anti-metabolite drugs market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 7.60% in the above mentioned forecast period. The study and analysis conducted in this industry report also helps to figure...